<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="style.css">
        <title> Omnibuster Section </title>
    </head>

    <body>
        <div class="section">
            <h1> Section s3121 </h1>
            <p> <section id="d3355e13583" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptI/sptC/s3121" style="-uslm-lc:I650144"><num value="3121">SEC. 3121. </num><heading>DISCONTINUANCE OR INTERRUPTION IN THE PRODUCTION OF MEDICAL DEVICES.</heading><content class="indent0 fontsize10" style="-uslm-lc:I650120">  Chapter V of the Federal Food, Drug, and Cosmetic Act (<a href="https://www.law.cornell.edu/uscode/text/21/351"><ref href="/us/usc/t21/s351/etseq">21 U.S.C. 351 et seq.</ref></a>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="insert">inserting</amendingAction> after section 506I the following:<quotedContent><section style="-uslm-lc:I650144"><num class="bold " value="506J">“SEC. 506J. </num><heading class="bold ">DISCONTINUANCE OR INTERRUPTION IN THE PRODUCTION OF MEDICAL DEVICES.</heading><subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="a">“(a) </num><heading><inline class="small-caps">In General</inline>.—</heading><chapeau>A manufacturer of a device that—</chapeau><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><content>is critical to public health during a public health emergency, including devices that are life-supporting, life-sustaining, or intended for use in emergency medical care or during surgery; or</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><content>for which the Secretary determines that information on potential meaningful supply disruptions of such device is needed during, or in advance of, a public health emergency;</content>
</paragraph>
<continuation class="indent0 fontsize10" style="-uslm-lc:I650120">shall, during, or in advance of, a public health emergency declared by the Secretary under section 319 of the Public Health Service Act, notify the Secretary, in accordance with subsection (b), of a permanent discontinuance in the manufacture of the device (except for discontinuances as a result of an approved modification of the device) or an interruption of the manufacture of the device that is likely to lead to a meaningful disruption in the supply of that device in the United States, and the reasons for such discontinuance or interruption.</continuation>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="b">“(b) </num><heading><inline class="small-caps">Timing</inline>.—</heading><chapeau>A notice required under subsection (a) shall be submitted to the Secretary—</chapeau><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><content>at least 6 months prior to the date of the discontinuance or interruption; or</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><content>if compliance with paragraph (1) is not possible, as soon as practicable.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="c">“(c) </num><heading><inline class="small-caps">Distribution</inline>.—</heading><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><heading><inline class="small-caps">Public availability</inline>.—</heading><content>To the maximum extent practicable, subject to paragraph (2), the Secretary shall distribute, through such means as the Secretary determines appropriate, information on the discontinuance or interruption of the manufacture of devices reported under subsection (a) to appropriate organizations, including physician, health provider, patient organizations, and supply chain partners, as appropriate and applicable, as described in subsection (g).</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><heading><inline class="small-caps">Public health exception</inline>.—</heading><content>The Secretary may choose not to make information collected under this section publicly available pursuant to this section if the Secretary determines that disclosure of such information would adversely affect the public health, such as by increasing the possibility of unnecessary over purchase of product, component parts, or other disruption of the availability of medical products to patients.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="d">“(d) </num><heading><inline class="small-caps">Confidentiality</inline>.—</heading><content>Nothing in this section shall be construed as authorizing the Secretary to disclose any information that is a trade secret or confidential information subject to <a href="https://www.law.cornell.edu/uscode/text/5/552"><ref href="/us/usc/t5/s552/b/4">section 552(b)(4) of title 5, United States Code</ref></a>, or <a href="https://www.law.cornell.edu/uscode/text/18/1905"><ref href="/us/usc/t18/s1905">section 1905 of title 18, United States Code</ref></a>.</content>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="e">“(e) </num><heading><inline class="small-caps">Failure To Meet Requirements</inline>.—</heading><chapeau>If a person fails to submit information required under subsection (a) in accordance with subsection (b)—</chapeau><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><content>the Secretary shall issue a letter to such person informing such person of such failure;</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><content>not later than 30 calendar days after the issuance of a letter under paragraph (1), the person who receives such letter shall submit to the Secretary a written response to such letter setting forth the basis for noncompliance and providing information required under subsection (a); and</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="3">“(3) </num><content>not later than 45 calendar days after the issuance of a letter under paragraph (1), the Secretary shall make such letter and any response to such letter under paragraph (2) available to the public on the internet website of the Food and Drug Administration, with appropriate redactions made to protect information described in subsection (d), except that, if the Secretary determines that the letter under paragraph (1) was issued in error or, after review of such response, the person had a reasonable basis for not notifying as required under subsection (a), the requirements of this paragraph shall not apply.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="f">“(f) </num><heading><inline class="small-caps">Expedited Inspections and Reviews</inline>.—</heading><chapeau>If, based on notifications described in subsection (a) or any other relevant information, the Secretary concludes that there is, or is likely to be, a shortage of an device, the Secretary shall, as appropriate—</chapeau><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><content>prioritize and expedite the review of a submission under section 513(f)(2), 515, review of a notification under section 510(k), or 520(m) for a device that could help mitigate or prevent such shortage; or</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><content>prioritize and expedite an inspection or reinspection of an establishment that could help mitigate or prevent such shortage.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="g">“(g) </num><heading><inline class="small-caps">Device Shortage List</inline>.—</heading><paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><heading><inline class="small-caps">Establishment</inline>.—</heading><content>The Secretary shall establish and maintain an up-to-date list of devices that are determined by the Secretary to be in shortage in the United States.</content>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><heading><inline class="small-caps">Contents</inline>.—</heading><chapeau>For each device included on the list under paragraph (1), the Secretary shall include the following information:</chapeau><subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="A">“(A) </num><content>The category or name of the device in shortage.</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="B">“(B) </num><content>The name of each manufacturer of such device.</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="C">“(C) </num><chapeau>The reason for the shortage, as determined by the Secretary, selecting from the following categories:</chapeau><clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="i">“(i) </num><content>Requirements related to complying with good manufacturing practices.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>Regulatory delay.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="iii">“(iii) </num><content>Shortage or discontinuance of a component or part.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="iv">“(iv) </num><content>Discontinuance of the manufacture of the device.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="v">“(v) </num><content>Delay in shipping of the device.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="vi">“(vi) </num><content>Delay in sterilization of the device.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="vii">“(vii) </num><content>Demand increase for the device.</content>
</clause>
<clause class="indent3 fontsize10" style="-uslm-lc:I650126"><num style="-uslm-lc:emspace2" value="viii">“(viii) </num><content>Facility closure.</content>
</clause>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="D">“(D) </num><content>The estimated duration of the shortage as determined by the Secretary.</content>
</subparagraph>
</paragraph>
<paragraph class="indent1 fontsize10" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="3">“(3) </num><heading><inline class="small-caps">Public availability</inline>.—</heading><subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="A">“(A) </num><heading><inline class="small-caps">In general</inline>.—</heading><content>Subject to subparagraphs (B) and (C), the Secretary shall make the information in the list under paragraph (1) publicly available.</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="B">“(B) </num><heading><inline class="small-caps">Trade secrets and confidential information</inline>.—</heading><content>Nothing in this subsection shall be construed to alter or amend <a href="https://www.law.cornell.edu/uscode/text/18/1905"><ref href="/us/usc/t18/s1905">section 1905 of title 18, United States Code</ref></a>, or section 552(b)(4) of title 5 of such Code.</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="C">“(C) </num><heading><inline class="small-caps">Public health exception</inline>.—</heading><content>The Secretary may elect not to make information collected under this subsection publicly available if the Secretary determines that disclosure of such information would adversely affect the public health (such as by increasing the possibility of hoarding or other disruption of the availability of the device to patients).</content>
</subparagraph>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="h">“(h) </num><heading><inline class="small-caps">Rule of Construction</inline>.—</heading><content>Nothing in this section shall be construed to affect the authority of the Secretary on the date of enactment of this section to expedite the review of devices under section 515 of the Federal Food, Drug, and Cosmetic Act, section 515B of such Act relating to the priority review program for devices, and section 564 of such Act relating to the emergency use authorization authorities.</content>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="i">“(i) </num><heading><inline class="small-caps">Definitions</inline>.—</heading><chapeau>In this section:</chapeau><paragraph class="indent1 fontsize10" role="definitions" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">“(1) </num><heading><inline class="small-caps">Meaningful disruption</inline>.—</heading><chapeau>The term ‘<term>meaningful disruption</term>’—</chapeau><subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="A">“(A) </num><content>means a change in production that is reasonably likely to lead to a reduction in the supply of a device by a manufacturer that is more than negligible and affects the ability of the manufacturer to fill orders or meet expected demand for its product;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="B">“(B) </num><content>does not include interruptions in manufacturing due to matters such as routine maintenance or insignificant changes in manufacturing so long as the manufacturer expects to resume operations in a short period of time, not to exceed 6 months;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="C">“(C) </num><content>does not include interruptions in manufacturing of components or raw materials so long as such interruptions do not result in a shortage of the device and the manufacturer expects to resume operations in a reasonable period of time; and</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" style="-uslm-lc:I650124"><num style="-uslm-lc:emspace2" value="D">“(D) </num><content>does not include interruptions in manufacturing that do not lead to a reduction in procedures or diagnostic tests associated with a medical device designed to perform more than one procedure or diagnostic test.</content>
</subparagraph>
</paragraph>
<paragraph class="indent1 fontsize10" role="definitions" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">“(2) </num><heading><inline class="small-caps">Shortage</inline>.—</heading><content>The term ‘<term>shortage</term>’, with respect to a device, means a period of time when the demand or projected demand for the device within the United States exceeds the supply of the device.”</content>
</paragraph>
</subsection>
</section>
</quotedContent>.</content>
</section></p>
        </div>  
    </body>